Eyelid Ptosis vs Brow Ptosis After Toxin

The patient comes back a few days after botulinum toxin saying her eye is "droopy" and her look has become heavy. You look at the face and need to quickly answer a question that changes the whole approach: what dropped, the eyelid or the brow? The two complaints look alike to the patient and are different for the exam, the explanation, and the plan. This guide helps separate the two, at a review level. Dose, injection point, and drug treatment are the decision of the qualified professional, according to the package insert and their council's rules, and are not described here.

What is the difference between the two?

Eyelid drooping is eyelid ptosis: the levator palpebrae superioris muscle loses strength and the eyelid descends over the eye, reducing the opening. Brow drooping is the lowering of the brow position, usually from weakening of the frontalis muscle, which normally lifts it.

Although the "heavy" look is common to both, the origin is different:

Why does eyelid ptosis happen?

The levator palpebrae superioris muscle lies deep relative to the corrugator muscle and the frontalis, in the orbital region. The literature describes that, after toxin in the glabellar and frontal region, eyelid ptosis can occur when the product spreads to that muscle. Spread may depend on factors such as the volume and position of the injection, massage afterward, and anatomical characteristics.

Some points to understand the context:

1. It is a described and known complication, and does not necessarily imply an error. Even so, technique and anatomy matter.
2. Toxin spread is a central concept. See also complications with botulinum toxin.
3. The effect is often unilateral, but it can be bilateral.
4. Time of onset is usually a few days, when the toxin sets in.
5. Regression is gradual, following the end of the effect.

Why does the brow drop?

Brow position depends on the balance between lifting forces (frontalis) and depressing forces (corrugator, procerus, orbicularis oculi, and depressor supercilii). Toxin in the forehead reduces the lifting force; if the effect is excessive or there is laxity, the brow drops. In people with heavy skin, an already low brow, or reliance on the frontalis to keep the eyes open, the risk is higher.

That is why the pre-procedure assessment of brow position is crucial. Asking the patient whether they use the forehead to keep the eyes open, and observing the face at rest and in movement, helps predict the risk. See muscle map for botulinum toxin and aging of the forehead and brow.

How to examine the patient?

The exam is quick and clarifying. The sequence below helps.

A common pitfall is the patient who already had mild ptosis or dermatochalasis and only noticed after the toxin. Before photos settle the question. See standardized clinical photography.

What approaches are usually described?

Management depends on the diagnosis, and belongs to the qualified professional. In general terms:

• Reassure with information: toxin ptosis is temporary and resolves when the effect ends. The patient needs to know this and what to expect.
• Avoid new toxin in the area until resolution, and avoid massage and manipulation.
• Consider supportive measures described in the literature for eyelid ptosis, which are prescribed by a qualified professional depending on the case, with attention to contraindications and side effects.
• In brow ptosis, planning any supplementation or adjustment must be careful, avoiding worsening the imbalance. Waiting for the effect to stabilize is often part of the approach.
• Refer when there are atypical signs, visual change, or diagnostic doubt.

How to talk to the patient?

The patient with a heavy look often feels affected in appearance and social life. A clear explanation, without minimizing and without alarming, is essential.

Avoid promising an exact timeline. Use ranges and return to the subject at the reassessment. See also communicating a result below expectations.

How does it evolve?

How to prevent it?

No measure eliminates the risk, but some reduce the chance:

1. Assess the anatomy and the previous brow position, especially in patients who rely on the frontalis.
2. Respect the anatomical limits of the area, particularly near the orbit.
3. Avoid volumes and dilutions that favor spread in risk areas, at the professional's discretion.
4. Tell the patient not to massage the area and to avoid lying down right afterward, according to the service's protocol.
5. Have a specific consent that mentions ptosis.
6. Record before and after photos for comparison.

What should be recorded?

In the patient record, record: area and product injected, complaint, onset date, exam (brow position, palpebral fissure, frontalis strength), differential diagnosis, instructions, management, and follow-ups. Include the explanation given to the patient. In cases with visual change, note the referral and the outcome.

In summary

A heavy look after toxin has at least two explanations, and management depends on separating them: the eyelid that drops (eyelid ptosis, from spread to the levator) and the brow that descends (from excess relaxation of the frontalis). The exam with before photos, attention to warning signs, a clear explanation to the patient, and an agreed follow-up turn a scare into a complication under monitoring.